Papers
2
Total Citations
27
H-Index
2
About
Jean-Marc Egly is a leading figure in biomedical robotics, with a focused expertise in developing automated systems for preclinical cancer research. His work centers on the critical challenge of precise, image-guided drug delivery, particularly for hepatocellular carcinoma (HCC), a notoriously difficult-to-treat liver cancer. Egly’s major contributions lie in the design and in vivo validation of robotized needle insertion systems coupled with µCT imaging. His pioneering 2014 study (14 citations) introduced a robotic platform for intratumoral drug evaluation in orthotopic HCC mouse models, directly addressing the limitations of manual, percutaneous injections. Complementing this, his 2013 work (13 citations) established a dedicated system for automated, repeated substance administration in small animals, enabling longitudinal studies of drug effects. These achievements are notable for translating precision engineering into tangible improvements in preclinical drug testing, enhancing both the accuracy and reproducibility of cancer research. Egly’s work stands as a cornerstone for the next generation of image-guided interventional robotics in oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2